Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03890107 · ClinicalTrials.gov registry record
Clinical Evaluation of the OtoSight
A clinical trial, sponsored by PhotoniCare.
- Completed
- Registry status
- 110
- Enrollment target
NCT03890107: Completed study, sponsored by PhotoniCare.
NCT03890107 is a clinical trial that has completed, run by PhotoniCare. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03890107 has completed, sponsored by PhotoniCare.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the imaging capabilities and image analysis performance of the OtoSight Middle Ear Scope in pediatric patients undergoing tympanostomy tube placement for otitis media. In this observational study, results of OtoSight imaging will not affect patient standard of care.
Primary Outcome
Optical coherence tomography imaging to evaluate the middle ear.
Interventions
- DEVICE OtoSight Middle Ear Scope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2022-04-30 |
What the finished NCT03890107 record still lists
NCT03890107 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which OtoSight Middle Ear Scope is the first listed.
NCT03890107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03890107 about?
NCT03890107 is a clinical study titled "Clinical Evaluation of the OtoSight". The objective of this study is to evaluate the imaging capabilities and image analysis performance of the OtoSight Middle Ear Scope in pediatric patients undergoing tympanostomy tube placement for otitis media. In this observational study, results of OtoSight imaging will not affect patient standard...
What is the current status of trial NCT03890107?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2019-04-15. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT03890107?
The interventions under investigation include: OtoSight Middle Ear Scope (DEVICE).
Who is sponsoring clinical trial NCT03890107?
This trial is sponsored by PhotoniCare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI